Angiotensin-(1–9) in hypertension

I Norambuena-Soto, C Lopez-Crisosto… - Biochemical …, 2022 - Elsevier
Abstract Angiotensin-(1–9)[Ang-(1–9)] is a peptide of the non-canonical renin-angiotensin
system (RAS) synthesized from angiotensin I by the monopeptidase angiotensin-converting …

Genetic landscape of the ACE2 coronavirus receptor

Z Yang, E Macdonald-Dunlop, J Chen, R Zhai, T Li… - Circulation, 2022 - Am Heart Assoc
Background: SARS-CoV-2, the causal agent of COVID-19, enters human cells using the
ACE2 (angiotensin-converting enzyme 2) protein as a receptor. ACE2 is thus key to the …

Angiotensin-Converting Enzyme (ACE) level, but not ACE gene polymorphism, is associated with prognosis of COVID-19 infection: Implications for diabetes and …

O Elbasan, F Bayram, CD Yazan, T Apaydın… - PloS one, 2023 - journals.plos.org
Background The renin-angiotensin-aldosterone system was shown to be activated in severe
COVID-19 infection. We aimed to investigate the relationship between angiotensin …

Multi-omics Investigations in Endocrine Systems and Their Clinical Implications

RA Peliciari-Garcia, CF de Barros, A Secio-Silva… - … -Based Approaches for …, 2024 - Springer
Innovative techniques such as the “omics” can be a powerful tool for the understanding of
intracellular pathways involved in homeostasis maintenance and identification of new …

Effect of Renin-Angiotensin-Aldosterone System Blockers on Adverse Outcomes in COVID-19 Patients

P Vinod, V Krishnappa, W Rathell Jr, G Dogbey… - Cardiology, 2024 - karger.com
Abstract Introduction: Angiotensin-converting enzyme 2 (ACE2) of the renin-angiotensin-
aldosterone system (RAAS) serves as a functional receptor to gain entry into the cells for …

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients

S Farid Fahmy, MO El Derany, H Khorshid… - BMC Pharmacology and …, 2023 - Springer
Background Renin–angiotensin–aldosterone system (RAAS) is hypothesized to be in the
center of COVID pathophysiology as the angiotensin converting enzyme 2 (ACE2) …

[HTML][HTML] Tace/Adam17 Substrates Associate with Acs (Ep-CAM, HB-EGF) and Follow-Up Mace (TNFR1 and TNFR2)

M Chemaly, R McAllister, A Peace, AJ Bjourson… - Atherosclerosis plus, 2022 - Elsevier
Background and aims TACE/ADAM17 is a membrane bound metalloprotease, which
cleaves substrates involved in immune and inflammatory responses and plays a role in …

[PDF][PDF] Could serum ACE2 levels predict infarct size in acute phase of ST-segment elevation myocardial infarction: a comparative study with classical biomarkers.

E Demirci, B Çalapkorur, S Karaçavuş… - European Review for …, 2022 - europeanreview.org
OBJECTIVE: Serum ACE2 level in the acute phase of ST-segment elevation myocardial
infarction may be an indicator of heart failure, however, limited studies have reported …

[HTML][HTML] Circulating angiotensin converting enzyme 2 and COVID-19

W Leowattana, T Leowattana… - World journal of clinical …, 2022 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered a
widespread outbreak since December 2019. The SARS-CoV-2 infection-related illness has …